DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023

Complete IRB-approved research study in Q2-2023 Commercialize BRAIN AGE™ in Q4-2023 TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED), an artificial intelligence-driven digital health company focusing on improving brain health, today provided an update on its development and commercialization plans and expected milestones in 2023 for BRAIN […]
See full article DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023 by Pet News 2Day
#PetFinancialNews
Comments
Post a Comment